James Fontanella-Khan
@JFK_America
@FT US Finance Editor, ex M&A reporter and correspondent in Brussels, Delhi & Mumbai. Co-creator Due Diligence & Scoreboard. Adj Pol Sci lecturer @CityCollegeNY
NEW: Alden Global Capital's MediaNews Group is making a last-minute bid for The Dallas Morning News, which reached a deal with Hearst earlier this month. MediaNews offering $16.50 a share to Hearst's $14 nytimes.com/2025/07/22/bus…
Scoop: Anti-woke warrior Bari Weiss seeks more than $200mn (up to $250mn!!) for media start-up The Free Press ft.com/content/0f1ce3… via @ft with @annaknicolaou @IvanLevingston @DanielThomasLDN
SCOOP Diageo to replace chief executive Debra Crew after share price slump; CFO Nik Jhangiani expected to become interim CEO. Shares up 3.6% after our story w/ @SpeedMaddie @AnjliRaval ft.com/content/aef5c1…
⏱️ 𝐑𝐈𝐒𝐔𝐋𝐓𝐀𝐓𝐎 𝐅𝐈𝐍𝐀𝐋𝐄 🇳🇴🇮🇹 #NorvegiaItalia 1️⃣-2️⃣ 50’, 90’ #Girelli; 66’ Hegerberg #WEURO2025 #Nazionale #Azzurre #LeAzzurreSiamoNoi
M&A bankers find dealmaking tough under Trump ft.com/content/ceae0e… via @ft
| Los inversores advierten que Donald Trump podría provocar otro shock en los mercados | Financial Times | Por Kate Duguid, Harriet Clarfelt @HClarfelt , James Fontanella-Khan @JFK_America y Amelia Pollard @ameliapollad | expansion.com/economia/finan…
Huge scoop by @mroliverbarnes 👏👏👏👏
SCOOP: Merck is nearing a roughly $10bn deal to buy lung disease-focused biotech Verona Pharma, the US drugmaker’s biggest acquisition in two years as it expands in respiratory medicine. Deal values Verona at $107 a share, likely to be announced as soon as Wednesday.
SCOOP: Merck is nearing a roughly $10bn deal to buy lung disease-focused biotech Verona Pharma, the US drugmaker’s biggest acquisition in two years as it expands in respiratory medicine. Deal values Verona at $107 a share, likely to be announced as soon as Wednesday.
Bessent is a Soros stooge. And he's a political science major who can't even do math. The polling for me was very positive a year ago, which is why Trump used me so much.
Tony Blair’s staff took part in ‘Gaza Riviera’ project with BCG on.ft.com/4nzq5VH via @financialtimes
periodic reminder that this is a partner at the most storied firm in Silicon Valley
U.S. bank M&A is expected to accelerate over the next year, driven by a friendlier regulatory environment, rising technology investment costs, and mounting competition. @MAmdorsky, @akilazoe & @JFK_America via @FT: ft.com/content/8a6a41…
billionaires should exist, really? A difficult case to make especially on moral grounds and when they’re not only ‘full’ citizens but uber citizens both politically and economically on.ft.com/402yCGt
After being narrowly passed by the US Senate today, @Sam1Fleming and I break down the contents of Trump's "big beautiful bill"
The US president is closing in on his goal of ramming $4.5tn of tax cuts through Congress, in a massive bill that would slash healthcare spending and drive up government borrowing. Here's what you need to know. on.ft.com/44dhwbq
Always a pleasure working with this super-talented team. This time we look at whether Europe is prepared for war. @rmilneNordic @samjoiner @Dan_Clark5 @inari_ta @janatausch @ian_bott_artist @BobHaslett ig.ft.com/russia-eastern… #dataviz #gistribe
Here is the full quote from President Trump when I asked him if he’ll deport Elon Musk: “I don’t know. We’ll have to take a look. We might have to put DOGE on Elon. You know what DOGE is? DOGE is the monster that might have to go back and eat Elon.”
Welcome to the club!
Brussels’ Atomium closes early because its balls are too hot ow.ly/lyvf106eqBU